Chromosomal microarray provides enhanced targetable gene aberration detection when paired with next generation sequencing panel in profiling lung and colorectal tumors

Cancer Genetics
S MukherjeeP A Lennon

Abstract

The development of targeted therapies based on specific genomic alterations has altered the treatment and management of lung and colorectal cancers. Chromosomal microarray (CMA) has allowed identification of copy number variations (CNVs) in lung and colorectal cancers in great detail, and next-generation sequencing (NGS) is used extensively to analyze the genome of cancers for molecular subtyping and use of molecularly guided therapies. The main objective of this study was to evaluate the utility of combining CMA and NGS for a comprehensive genomic assessment of lung and colorectal adenocarcinomas, especially for detecting drug targets. We compared the results from NGS and CMA data from 60 lung and 51 colorectal tumors. From CMA analysis, 33% were amplified, 89% showed gains, 75% showed losses and 41% demonstrated loss of heterozygosity; pathogenic variants were identified in 81% of colon and 67% lung specimens through NGS. KRAS mutations commonly occurred with loss in TP53 and there was significant loss of BRCA1 and NF1 among male patients with lung cancer. For clinically actionable targets, 23% had targetable CNVs when no pathogenic variants were detected by NGS. The data thus indicate that combining the two approaches provid...Continue Reading

References

Oct 27, 1989·Science·T TakahashiJ D Minna
Mar 27, 2001·Nature Reviews. Genetics·L Liotta, E Petricoin
Apr 20, 2001·The New England Journal of Medicine·T WatanabeS R Hamilton
May 7, 2004·Proceedings of the National Academy of Sciences of the United States of America·Emma Hitt
Apr 20, 2005·Nature Genetics·Kevin L GundersonMark S Chee
May 4, 2005·Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology·Jonathan J DaviesWan L Lam
Jun 29, 2005·Proceedings of the National Academy of Sciences of the United States of America·Giovanni TononRonald A Depinho
Sep 8, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tatsuhiro ShibataSetsuo Hirohashi
Sep 30, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ramaswamy GovindanJay Piccirillo
Oct 6, 2006·PLoS Medicine·Anju SinghShyam Biswal
Sep 1, 2007·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Peter GoldstrawUNKNOWN Participating Institutions
Oct 13, 2007·Science·Laura D WoodBert Vogelstein
Apr 5, 2008·Human Mutation·Pedro P MedinaMontse Sanchez-Cespedes
Sep 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Eri AraiYae Kanai
Jul 9, 2010·CA: a Cancer Journal for Clinicians·Ahmedin JemalElizabeth Ward
Oct 29, 2010·The New England Journal of Medicine·Eunice L KwakA John Iafrate
Jan 11, 2011·Briefings in Functional Genomics·Ruibin XiPeter J Park
May 31, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Sai-Hong Ignatius OuA John Iafrate
Nov 30, 2011·Nature Reviews. Genetics·Todd J Treangen, Steven L Salzberg
Jan 5, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kristin BergethonA John Iafrate
Apr 27, 2013·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Linda D CooleyUNKNOWN Working Group of the American College of Medical Genetics and Genomics (ACMG) Laboratory Quality Assurance Committee
Sep 13, 2013·The New England Journal of Medicine·Jean-Yves DouillardScott D Patterson
Sep 28, 2013·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Sarah T SouthUNKNOWN Working Group for the American College of Medical Genetics and Genomics Laboratory Quality Assurance Committee
Dec 25, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R KastnerC Gabriel
Jan 15, 2014·Current Opinion in Oncology·Antonio M GrimaldiPaolo A Ascierto
Aug 15, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Shigeki UmemuraKoichi Goto
Jan 6, 2015·Cancer·Luc G T Morris, Timothy A Chan
Apr 8, 2015·Case Reports in Oncology·Raphael Brandão MoreiraMarcelo Rocha de Sousa Cruz

❮ Previous
Next ❯

Citations

Feb 22, 2017·Journal of Pathology and Translational Medicine·Hye Seung LeeUNKNOWN Molecular Pathology Study Group of Korean Society of Pathologists

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.